JP2017532285A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017532285A5 JP2017532285A5 JP2016549442A JP2016549442A JP2017532285A5 JP 2017532285 A5 JP2017532285 A5 JP 2017532285A5 JP 2016549442 A JP2016549442 A JP 2016549442A JP 2016549442 A JP2016549442 A JP 2016549442A JP 2017532285 A5 JP2017532285 A5 JP 2017532285A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- bcl
- nutrin
- inhibiting
- mdm2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (23)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461932711P | 2014-01-28 | 2014-01-28 | |
| US201461932704P | 2014-01-28 | 2014-01-28 | |
| US61/932,704 | 2014-01-28 | ||
| US61/932,711 | 2014-01-28 | ||
| US201461979911P | 2014-04-15 | 2014-04-15 | |
| US61/979,911 | 2014-04-15 | ||
| US201462002709P | 2014-05-23 | 2014-05-23 | |
| US62/002,709 | 2014-05-23 | ||
| US201462042708P | 2014-08-27 | 2014-08-27 | |
| US62/042,708 | 2014-08-27 | ||
| US201462044664P | 2014-09-02 | 2014-09-02 | |
| US62/044,664 | 2014-09-02 | ||
| US201462057820P | 2014-09-30 | 2014-09-30 | |
| US201462057825P | 2014-09-30 | 2014-09-30 | |
| US201462057828P | 2014-09-30 | 2014-09-30 | |
| US62/057,820 | 2014-09-30 | ||
| US62/057,828 | 2014-09-30 | ||
| US62/057,825 | 2014-09-30 | ||
| US201462061627P | 2014-10-08 | 2014-10-08 | |
| US201462061629P | 2014-10-08 | 2014-10-08 | |
| US62/061,627 | 2014-10-08 | ||
| US62/061,629 | 2014-10-08 | ||
| PCT/US2015/013387 WO2015116740A1 (en) | 2014-01-28 | 2015-01-28 | Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019083555A Division JP2019142933A (ja) | 2014-01-28 | 2019-04-25 | 病変した組織から老化細胞を除去することにより眼の疾患、肺の疾患またはアテローム性動脈硬化を処置するための医薬 |
| JP2020038529A Division JP2020105213A (ja) | 2014-01-28 | 2020-03-06 | 病変した組織から老化細胞を除去することにより眼の疾患、肺の疾患またはアテローム性動脈硬化を処置するための医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017532285A JP2017532285A (ja) | 2017-11-02 |
| JP2017532285A5 true JP2017532285A5 (https=) | 2018-03-08 |
| JP6688224B2 JP6688224B2 (ja) | 2020-04-28 |
Family
ID=53757701
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549442A Expired - Fee Related JP6688224B2 (ja) | 2014-01-28 | 2015-01-28 | Ｍｄｍ２を阻害する手段の投与による関節における変形性関節症の処置 |
| JP2019083555A Pending JP2019142933A (ja) | 2014-01-28 | 2019-04-25 | 病変した組織から老化細胞を除去することにより眼の疾患、肺の疾患またはアテローム性動脈硬化を処置するための医薬 |
| JP2020038529A Withdrawn JP2020105213A (ja) | 2014-01-28 | 2020-03-06 | 病変した組織から老化細胞を除去することにより眼の疾患、肺の疾患またはアテローム性動脈硬化を処置するための医薬 |
| JP2021081356A Pending JP2021138712A (ja) | 2014-01-28 | 2021-05-13 | 老化細胞を殺し、老化関連疾患および障害を処置するための方法と組成物 |
| JP2023110762A Pending JP2023126918A (ja) | 2014-01-28 | 2023-07-05 | 老化細胞を殺し、老化関連疾患および障害を処置するための方法と組成物 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019083555A Pending JP2019142933A (ja) | 2014-01-28 | 2019-04-25 | 病変した組織から老化細胞を除去することにより眼の疾患、肺の疾患またはアテローム性動脈硬化を処置するための医薬 |
| JP2020038529A Withdrawn JP2020105213A (ja) | 2014-01-28 | 2020-03-06 | 病変した組織から老化細胞を除去することにより眼の疾患、肺の疾患またはアテローム性動脈硬化を処置するための医薬 |
| JP2021081356A Pending JP2021138712A (ja) | 2014-01-28 | 2021-05-13 | 老化細胞を殺し、老化関連疾患および障害を処置するための方法と組成物 |
| JP2023110762A Pending JP2023126918A (ja) | 2014-01-28 | 2023-07-05 | 老化細胞を殺し、老化関連疾患および障害を処置するための方法と組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (19) | US9993472B2 (https=) |
| EP (2) | EP3099380B1 (https=) |
| JP (5) | JP6688224B2 (https=) |
| KR (1) | KR102496146B1 (https=) |
| CN (3) | CN112274641A (https=) |
| AU (4) | AU2015211021B2 (https=) |
| BR (1) | BR112016017564A8 (https=) |
| CA (2) | CA3100140C (https=) |
| IL (3) | IL286427B2 (https=) |
| MX (2) | MX2016009753A (https=) |
| NZ (1) | NZ723035A (https=) |
| RU (1) | RU2716256C2 (https=) |
| SG (2) | SG10201805670QA (https=) |
| WO (1) | WO2015116740A1 (https=) |
Families Citing this family (121)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2553225C2 (ru) | 2008-05-23 | 2015-06-10 | Сива Корпорейшн | Способ облегчения регенерации |
| ES2725852T3 (es) | 2010-09-27 | 2019-09-27 | Siwa Corp | Eliminación selectiva de células modificadas por AGE para el tratamiento de la aterosclerosis |
| US8721571B2 (en) | 2010-11-22 | 2014-05-13 | Siwa Corporation | Selective removal of cells having accumulated agents |
| US20190269675A1 (en) | 2014-01-28 | 2019-09-05 | Buck Institute for Research and Aging | Treatment of parkinson's disease and other conditions caused or mediated by senescent astrocytes using small molecule senolytic agents |
| US20170216286A1 (en) | 2014-01-28 | 2017-08-03 | Mayo Foundation For Medical Education And Research | Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid |
| US10328058B2 (en) | 2014-01-28 | 2019-06-25 | Mayo Foundation For Medical Education And Research | Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques |
| IL286427B2 (en) | 2014-01-28 | 2024-08-01 | Mayo Found Medical Education & Res | Inhibitors bcl-2 anti-apoptotic protein family members for treatment of non cancer pulmonary disease or an opthalmic disease |
| EP3139942B1 (en) | 2014-05-05 | 2019-12-18 | Bioventures, Llc | COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS |
| WO2015171723A1 (en) * | 2014-05-06 | 2015-11-12 | Research Development Foundation | Methods for treating insulin resistance and for sensitizing patients to glp1 agonist therapy |
| WO2016014625A1 (en) | 2014-07-22 | 2016-01-28 | Board Of Trustees Of The University Of Arkansas | Compositions and methods for selectively depleting senescent cells |
| EP3194439B1 (en) | 2014-09-19 | 2022-01-19 | Siwa Corporation | Anti-age antibodies for treating inflammation and auto-immune disorders |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| US20180000816A1 (en) * | 2015-02-06 | 2018-01-04 | Unity Biotechnology, Inc. | Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions |
| WO2016127135A1 (en) * | 2015-02-06 | 2016-08-11 | Unity Biotechnology, Inc. | Compounds and uses in treatment of senescence-associated conditons |
| WO2016135732A1 (en) * | 2015-02-26 | 2016-09-01 | Yeda Research And Development Co. Ltd. | Method of promoting hair growth |
| US10195213B2 (en) | 2015-03-13 | 2019-02-05 | Unity Biotechnology, Inc. | Chemical entities that kill senescent cells for use in treating age-related disease |
| WO2017002120A1 (en) * | 2015-07-02 | 2017-01-05 | Yeda Research And Development Co. Ltd. | Selective inhibitors of senescent cells and uses thereof |
| WO2017101851A1 (en) * | 2015-12-18 | 2017-06-22 | Unity Biotechnology, Inc. | Acylsulfonamide derivatives for treating senescence-associated diseases and disorders |
| HUE058854T2 (hu) | 2016-02-19 | 2022-09-28 | Siwa Corp | Módszer és készítmény a rák kezelésére, az áttétes rákos sejtek elpusztítására és a rák áttétképzõdésének megelõzésére a fejlett glikációs végtermékek (AGE) elleni antitest alkalmazásával |
| CA3017408C (en) * | 2016-03-15 | 2025-08-19 | Oryzon Genomics, S.A. | LSD1 INHIBITOR COMBINATIONS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNITIS |
| KR20180133452A (ko) | 2016-04-15 | 2018-12-14 | 시와 코퍼레이션 | 신경퇴행성 질환을 치료하기 위한 항-노화 항체 |
| US20190054097A1 (en) * | 2016-04-21 | 2019-02-21 | Bioventures, Llc | Compositions targeting senescent cells and the uses thereof |
| CN109152933B (zh) * | 2016-04-21 | 2022-12-02 | 生物风险投资有限责任公司 | 诱导抗细胞凋亡bcl-2家族蛋白的降解的化合物及其用途 |
| WO2017223107A1 (en) * | 2016-06-20 | 2017-12-28 | Unity Biotechnology, Inc. | Genome modifying enzyme therapy for diseases modulated by senescent cells |
| JP2019518763A (ja) | 2016-06-23 | 2019-07-04 | シワ コーポレーション | 様々な疾患及び障害の治療において使用するためのワクチン |
| JP7077335B2 (ja) | 2016-12-13 | 2022-05-30 | プリンストン ドラッグ ディスカバリー インコーポレイテッド | プロテインキナーゼ阻害剤 |
| US20210230221A1 (en) | 2017-01-03 | 2021-07-29 | Bioatla, Llc | Protein therapeutics for treatment of senescent cells |
| US20240044046A1 (en) * | 2017-01-03 | 2024-02-08 | Bioatla, Inc. | Protein therapeutics for treatment of senescent cells |
| US10961321B1 (en) | 2017-01-06 | 2021-03-30 | Siwa Corporation | Methods and compositions for treating pain associated with inflammation |
| US10858449B1 (en) | 2017-01-06 | 2020-12-08 | Siwa Corporation | Methods and compositions for treating osteoarthritis |
| US10925937B1 (en) | 2017-01-06 | 2021-02-23 | Siwa Corporation | Vaccines for use in treating juvenile disorders associated with inflammation |
| US10995151B1 (en) | 2017-01-06 | 2021-05-04 | Siwa Corporation | Methods and compositions for treating disease-related cachexia |
| EP3593134A1 (en) * | 2017-03-09 | 2020-01-15 | Cleara Biotech B.V. | Biomarkers for cellular senescence |
| CA3059803A1 (en) | 2017-04-13 | 2018-10-18 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody |
| TWI651087B (zh) * | 2017-04-21 | 2019-02-21 | Chang Gung University | 類泛素化抑制劑於預防或治療骨質疏鬆症的用途 |
| US20200150131A1 (en) * | 2017-05-04 | 2020-05-14 | Siwa Corporation | Diagnostic advanced glycation end-product antibodies |
| AU2018202878A1 (en) * | 2017-05-16 | 2018-12-06 | Allarity Therapeutics Europe ApS | Methods for predicting drug responsiveness in cancer patients |
| JP2020520906A (ja) * | 2017-05-19 | 2020-07-16 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 肺高血圧症の治療のためのエンザスタウリン及び脆弱性ヒスチジン三連構造（ｆｈｉｔ）増加剤 |
| GB201708456D0 (en) * | 2017-05-26 | 2017-07-12 | Medical Res Council | Senolytic compounds |
| US20180344865A1 (en) * | 2017-05-31 | 2018-12-06 | Palo Alto Investors | Methods of Increasing Fertility in a Female Subject |
| CN110088081A (zh) | 2017-06-16 | 2019-08-02 | 尤尼蒂生物技术公司 | 制备用于药物用途的对映纯顺式-咪唑啉化合物的合成方法 |
| US20200354336A9 (en) | 2017-08-11 | 2020-11-12 | Unity Biotechnology, Inc. | Treatment of Lung Diseases Using Pharmaceutical Agents that Eliminate Senescent Cells |
| WO2019033119A1 (en) * | 2017-08-11 | 2019-02-14 | Unity Biotechnology, Inc. | TREATMENT OF OPHTHALMIC CONDITIONS SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS |
| EP3691627A4 (en) * | 2017-10-06 | 2021-10-20 | Buck Institute for Research on Aging | BIOMARKER FOR SENESCENT CELLS |
| US10588916B2 (en) | 2017-10-31 | 2020-03-17 | Unity Biotechnology, Inc. | Technology to inhibit vascular changes that lead to vision loss in the eye |
| US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
| US10689416B2 (en) | 2017-12-30 | 2020-06-23 | Unity Biotechnology, Inc. | Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer |
| WO2019133904A1 (en) * | 2017-12-30 | 2019-07-04 | Unity Biotechnology, Inc. | Inhibitors of hsp90, pi3-kinase, proteasome, hdac, and p97 pathways for selective removal of senescent cells in the treatment of age related conditions |
| AU2018357829B2 (en) | 2017-12-30 | 2019-09-26 | Unity Biotechnology, Inc. | Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer |
| ES3041854T3 (en) * | 2018-01-22 | 2025-11-17 | Bioventures Llc | Bcl-2 proteins degraders for cancer treatment |
| CN112136048A (zh) * | 2018-02-21 | 2020-12-25 | 艾迪菲斯健康有限公司 | 测量全身性慢性炎性衰老的方法 |
| WO2019183282A1 (en) * | 2018-03-21 | 2019-09-26 | Mayo Foundation For Medical Education And Research | Senolytic agents for the treatment of tauopathies |
| WO2019198091A1 (en) | 2018-04-12 | 2019-10-17 | Yeda Research And Development Co. Ltd. | Blood based treatment |
| CA3056878C (en) | 2018-04-30 | 2021-03-30 | Unity Biotechnology | Phospholidines that are bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer |
| US10738042B2 (en) | 2018-04-30 | 2020-08-11 | Unity Biotechnology, Inc. | Phosphonamidates that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer |
| IL319432A (en) * | 2018-04-30 | 2025-05-01 | Kartos Therapeutics Inc | Methods of treating cancer |
| CN117866015A (zh) | 2018-04-30 | 2024-04-12 | 联合生物科技公司 | 一种临床管理中使用的化合物及其用途 |
| JP7402225B2 (ja) | 2018-05-11 | 2023-12-20 | ロード アイランド ホスピタル | ヌクレオシド系逆転写酵素阻害剤を用いて関節障害を処置するための組成物および方法 |
| US12084423B2 (en) | 2018-05-18 | 2024-09-10 | Bioventures, Llc | Piperlongumine analogues and uses thereof |
| KR20210019459A (ko) * | 2018-05-24 | 2021-02-22 | 레니버스 테라퓨틱스, 인크. | 신장 손상 및 신부전 위험이 있는 환자를 치료하는 방법 |
| US11003537B2 (en) | 2018-05-29 | 2021-05-11 | Micron Technology, Inc. | Determining validity of data read from memory by a controller |
| US10717722B2 (en) | 2018-06-13 | 2020-07-21 | Unity Biotechnology, Inc. | Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer |
| EP3809983B1 (en) | 2018-06-22 | 2025-08-27 | Mayo Foundation for Medical Education and Research | Methods and materials for improving arteriovenous fistula maturation and maintaining arteriovenous fistula functionality |
| US11026963B2 (en) * | 2018-07-11 | 2021-06-08 | Rubedo Life Sciences, Inc. | Senolytic compositions and uses thereof |
| CN112673259B (zh) * | 2018-07-20 | 2024-11-22 | 豪夫迈·罗氏有限公司 | 基于igfbp-7的先兆子痫预测 |
| CN109406764B (zh) * | 2018-09-13 | 2022-02-01 | 中国辐射防护研究院 | 腹腔放疗后药物体内过程评价动物模型的建立与评价方法 |
| SG11202101955SA (en) * | 2018-09-18 | 2021-03-30 | Signalchem Lifesciences Corp | Combination therapy for treating blood cancer |
| US20210361774A1 (en) | 2018-10-16 | 2021-11-25 | Dana-Farber Cancer Institute, Inc. | Degraders of wild-type and mutant forms of lrrk2 |
| WO2020119614A1 (en) * | 2018-12-14 | 2020-06-18 | Ascentage Pharma (Suzhou) Co., Ltd. | A compound for treating osteoarthritis |
| EP3897616A4 (en) * | 2018-12-20 | 2022-03-16 | Mayo Foundation for Medical Education and Research | METHODS AND MATERIALS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS |
| WO2020150394A1 (en) * | 2019-01-15 | 2020-07-23 | The Johns Hopkins University | Regulation of a foreign body response |
| FR3091864B1 (fr) | 2019-01-20 | 2022-07-29 | Waterdiam France | Eau électrolysée, procédé d’obtention et utilisations d’une telle eau pour le traitement de désordres liés à la sénescence cellulaire |
| EP3914604B1 (en) | 2019-01-25 | 2026-03-04 | Brown University | Compositions comprising censavudine or elvucitabine for treating age-associated inflammation and disorders |
| CN111494366A (zh) * | 2019-01-31 | 2020-08-07 | 洛阳尚德药缘科技有限公司 | 二甲基氨基含笑内酯在制备抗衰老药物上的应用 |
| CN110161226A (zh) * | 2019-02-27 | 2019-08-23 | 杭州晟康细胞生物科技有限公司 | 一种检测衰老细胞用的抗体、试剂盒及检测方法 |
| EP3705109A1 (en) | 2019-03-05 | 2020-09-09 | Greenaltech, S.L. | Carotenoids in the treatment of senescence-related diseases |
| EP4365590B1 (en) | 2019-03-20 | 2025-09-24 | Juntendo Educational Foundation | Agent targeting double-membrane organelle dna |
| EP3947368B1 (en) | 2019-04-04 | 2025-09-03 | Dana-Farber Cancer Institute, Inc. | Bifunctional compounds comprising a cdk2/5 ligand, a linker and a e3 ubiquitin ligase binding degron for the treatment of cancer |
| CN114126599A (zh) * | 2019-06-10 | 2022-03-01 | 巴克老龄化研究所 | 改变衰老相关分泌表型的方法和组合物 |
| WO2020257173A1 (en) * | 2019-06-17 | 2020-12-24 | Unity Biotechnology, Inc. | Method of treating the osteoarthritic joint |
| CN111407884B (zh) * | 2019-06-24 | 2021-12-07 | 浙江大学 | 促生长激素释放激素激动剂ghrh-a在制备抗衰老药物中的用途 |
| CN110934873B (zh) * | 2019-08-22 | 2022-10-28 | 中国科学院上海营养与健康研究所 | 靶向组织微环境中衰老细胞的抗衰老药物d/s及其应用 |
| CN112707900B (zh) * | 2019-10-24 | 2022-06-10 | 上海科技大学 | 蛋白降解剂及其在疾病治疗中的应用 |
| KR20220098755A (ko) | 2019-11-05 | 2022-07-12 | 애브비 인코포레이티드 | 나비토클락스를 사용한 골수섬유증 및 mpn 관련 장애 치료에 사용하기 위한 투약 레지멘 |
| US20220396841A1 (en) * | 2019-12-02 | 2022-12-15 | Viome Life Sciences, Inc. | Detection and elimination of aberrant cells |
| US12441722B2 (en) | 2020-01-15 | 2025-10-14 | University Of Florida Research Foundation, Incorporated | Therapeutic agents and methods of treatment |
| KR20230005160A (ko) | 2020-03-19 | 2023-01-09 | 카이메라 쎄라퓨틱스 인코포레이티드 | Mdm2 분해제 및 이의 용도 |
| JP2023522979A (ja) * | 2020-04-23 | 2023-06-01 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ｉＮＫＴ細胞の活性化による老化細胞の排除 |
| CA3181134A1 (en) * | 2020-06-02 | 2021-12-09 | Christopher D. WILEY | Dihomo-gamma linolenic acid (dgla) is a novel senolytic |
| US20230233561A1 (en) * | 2020-06-17 | 2023-07-27 | Mayo Foundation For Medical Education And Research | Assessing and treating biological aging |
| CN111973578A (zh) * | 2020-08-03 | 2020-11-24 | 天津医科大学 | C188-9、Venetoclax、Bumetanide在纤维化疾病药物中的应用 |
| KR20220056730A (ko) * | 2020-10-28 | 2022-05-06 | 의료법인 성광의료재단 | Abt263을 유효성분으로 포함하는 디스크 질환 예방 및 치료용 조성물 |
| CN112294962B (zh) * | 2020-11-13 | 2023-06-06 | 上海长海医院 | Bcl-2及bcl-xl抑制剂在瘢痕治疗中的应用 |
| CN112891358B (zh) * | 2020-11-19 | 2023-05-12 | 苏州正永生物医药有限公司 | Bcl-2抑制剂的应用及治疗衰老相关皮肤病的药物组合物 |
| JPWO2022138700A1 (https=) * | 2020-12-23 | 2022-06-30 | ||
| US20240117349A1 (en) * | 2021-01-29 | 2024-04-11 | Alnylam Pharmaceuticals, Inc. | iRNA COMPOSITIONS AND METHODS FOR SILENCING AMYLOID PRECURSOR PROTEIN (APP) |
| KR102625248B1 (ko) * | 2021-05-04 | 2024-01-16 | 주식회사 퓨전바이오텍 | 이미다졸린 유도체 화합물을 유효성분으로 포함하는 황반 변성 치료용 약학적 조성물 |
| CN113341126A (zh) * | 2021-05-07 | 2021-09-03 | 中国科学院动物研究所 | 一种评价或辅助评价海马组织衰老的标志物 |
| EP4366720A4 (en) * | 2021-07-09 | 2025-05-07 | Georgia State University Research Foundation, Inc. | The use of beta-hydroxybutyrates for the treatment or prevention of aneurysms and dissections |
| CN113509555B (zh) * | 2021-07-19 | 2022-05-03 | 中国药科大学 | Akt2抑制剂在制备非酒精性脂肪肝病治疗药物中的应用 |
| EP4388016A1 (en) | 2021-08-20 | 2024-06-26 | Siwa Corporation | Methods and compositions for treating fibrotic diseases |
| AU2022328858A1 (en) * | 2021-08-20 | 2024-02-22 | The Brain Protection Company PTY LTD | Combinatorial therapies including implantable damping devices and therapeutic agents for treating a condition and associated systems and methods of use |
| CN113694071B (zh) * | 2021-08-31 | 2025-08-15 | 上海交通大学医学院附属瑞金医院 | 清除和/或溶解衰老细胞和/或抑制细胞衰老的化合物用于治疗精神障碍 |
| EP4380575A4 (en) * | 2021-09-13 | 2025-07-23 | Rubedo Life Sciences Inc | DRUG CONJUGATES OF SUGAR DERIVATIVES AND THEIR USES AS SENOLYTIC AGENTS |
| WO2023039292A2 (en) * | 2021-09-13 | 2023-03-16 | Rubedo Life Sciences, Inc. | Novel sugar derivatives and uses thereof to prepare novel senolytic agents |
| US20240398764A1 (en) * | 2021-10-12 | 2024-12-05 | University Of Florida Research Foundation, Incorporated | Methods of treating diseases associated with senescent cell accumulation |
| WO2023096448A1 (ko) * | 2021-11-29 | 2023-06-01 | 에스케이케미칼 주식회사 | 오바토클락스 대사성 질환 및 섬유화 질환 치료 용도 |
| WO2023146979A1 (en) * | 2022-01-27 | 2023-08-03 | The Board Of Trustees Of The Leland Stanford Junior University | A single cell mass cytometry platform to map the effects of candidate agents on cartilage |
| WO2023191513A1 (ko) * | 2022-03-29 | 2023-10-05 | 주식회사 퓨전바이오텍 | 당 결합된 이미다졸린 유도체 및 이의 용도 |
| KR102879114B1 (ko) * | 2022-03-29 | 2025-11-05 | 주식회사 퓨전바이오텍 | 당 결합된 이미다졸린 유도체 및 이의 용도 |
| EP4531876A4 (en) * | 2022-06-01 | 2026-03-25 | Sens Res Foundation | TARGETED ELIMINATION OF SENESCENT CELLS BY GAMMA-DELTA T LYMPHOCYTES |
| US12263152B2 (en) | 2022-07-01 | 2025-04-01 | Jjr&D, Llc | Method of preventing and treating chemotherapy-induced alopecia |
| WO2024039646A1 (en) * | 2022-08-15 | 2024-02-22 | Mayo Foundation For Medical Education And Research | Methods and materials for using and assessing anti-senescence treatments within mammals |
| CN118063438A (zh) * | 2022-11-14 | 2024-05-24 | 北京华益健康药物研究中心 | Mdm2/mdmx双靶点抑制剂化合物、前药、药物组合物及其制备方法和应用 |
| EP4649499A1 (en) * | 2023-01-12 | 2025-11-19 | Koninklijke Philips N.V. | Model-guided imaging for mechanical ventilation |
| WO2024229271A1 (en) * | 2023-05-03 | 2024-11-07 | Memorial Sloan-Kettering Cancer Center | Nanoparticle-based theranostic platform for diagnosis and treatment of senescence-related pathologies |
| WO2025054580A1 (en) * | 2023-09-08 | 2025-03-13 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Compositions and methods for increasing myocardial capillary formation, reducing left ventricular hypertrophy and/or reducing ventricular dysfunction |
| TW202519194A (zh) * | 2023-11-03 | 2025-05-16 | 台灣微脂體股份有限公司 | 用於疼痛控制之關節內皮質類固醇的微脂體組成物 |
| WO2025117556A1 (en) * | 2023-11-27 | 2025-06-05 | Rubedo Life Sciences, Inc. | Phosphorous containing bcl inhibitors and senolytic compounds and uses thereof |
| KR20260001876A (ko) | 2024-06-28 | 2026-01-06 | 바이오스펙트럼 주식회사 | 발효 동백종자 추출물을 포함하는 일주기 리듬 장애 또는 세포 노화 예방 또는 개선용 조성물 |
Family Cites Families (161)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1021342A (en) | 1910-04-20 | 1912-03-26 | James D Swindell | Furnace. |
| US1025861A (en) | 1911-12-12 | 1912-05-07 | John Martin Case | Train-order holder. |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5723286A (en) | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
| US5270170A (en) | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
| US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
| DE69309472T2 (de) | 1992-01-23 | 1997-10-23 | Merck Patent Gmbh, 64293 Darmstadt | Fusionsproteine von monomeren und dimeren von antikörperfragmenten |
| EP0786522A2 (en) | 1992-07-17 | 1997-07-30 | Ribozyme Pharmaceuticals, Inc. | Enzymatic RNA molecules for treatment of stenotic conditions |
| US5700638A (en) | 1993-08-26 | 1997-12-23 | Washington University | Cell death regulator |
| US5922545A (en) | 1993-10-29 | 1999-07-13 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| DK0934526T3 (da) | 1996-10-08 | 2003-05-05 | Bisys B V U | Fremgangsmåder og midler til udvælgelse af peptider og proteiner, der har specifik affinitet til et mål |
| EP1009390A4 (en) | 1997-07-02 | 2004-05-06 | Euro Celtique Sa | LONG-EFFECT ANESTHESIA INJECTED IN JOINT AND BODY SPACES |
| US6395713B1 (en) | 1997-07-23 | 2002-05-28 | Ribozyme Pharmaceuticals, Inc. | Compositions for the delivery of negatively charged molecules |
| DE69941447D1 (de) | 1998-01-05 | 2009-11-05 | Univ Washington | Erhöhter transport unter benutzung membranzerstörender stoffe |
| US20020197602A1 (en) | 1998-04-15 | 2002-12-26 | Glenna C. Burmer | Nucleic acid sequences and proteins associated with aging |
| US6664443B1 (en) | 1998-05-01 | 2003-12-16 | Mayo Foundation For Medical Education And Research | Pathogenic Tau mutations in transgenic mice |
| US20020068704A1 (en) | 1999-04-05 | 2002-06-06 | Ziegler Randy H. | Compositions and methods for treatment of diabetes |
| GB9910119D0 (en) | 1999-04-30 | 1999-06-30 | Novartis Ag | Organic compounds |
| IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
| US6656461B1 (en) | 2000-02-29 | 2003-12-02 | The Trustees Of Columbia University In The City Of New York | Therapeutic treatment of chronic obstructive pulmonary disease |
| AR031130A1 (es) | 2000-09-20 | 2003-09-10 | Abbott Lab | N-acilsulfonamidas promotoras de la apoptosis |
| CA2454976C (en) | 2001-07-26 | 2011-05-10 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for glaucoma comprising compound having pi3 kinase inhibitory action as active ingredient |
| WO2003028443A1 (en) | 2001-09-28 | 2003-04-10 | The Walter And Eliza Hall Institute Of Medical Research | Screening methods for agents that modulate degenerative disorders associated with bcl-2-and bim |
| US20030086916A1 (en) | 2001-10-12 | 2003-05-08 | Goligorsky Michael S. | Use of peroxynitrite scavengers or peroxynitrite formation inhibitors that do not diminish nitric oxide synthesis or activity to reverse or prevent premature vascular senescence |
| ATE397925T1 (de) | 2001-12-18 | 2008-07-15 | Hoffmann La Roche | Cis-imidazoline als mdm2-hemmer |
| PL370823A1 (en) | 2001-12-18 | 2005-05-30 | F.Hoffmann-La Roche Ag | Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| AU2002303023A1 (en) | 2002-06-05 | 2003-12-22 | Metabolic Engineering Laboratories Co., Ltd. | Signals and molecular species involved in senescence |
| FI117094B (fi) * | 2003-01-15 | 2006-06-15 | Fractivator Oy | Menetelmä orgaanisen jätteen hajottamiseksi |
| WO2005001080A2 (en) * | 2003-06-27 | 2005-01-06 | Ethicon, Incorporated | Postpartum-derived cells for use in treatment of disease of the heart and circulatory system |
| KR20060111898A (ko) * | 2003-08-29 | 2006-10-30 | 교와 가부시키가이샤 | 지질-풍부-플라크의 안정화 방법 및 파열 예방방법 |
| US7767684B2 (en) | 2003-11-13 | 2010-08-03 | Abbott Laboratories | Apoptosis promoters |
| WO2005049593A2 (en) | 2003-11-13 | 2005-06-02 | Abbott Laboratories | N-acylsulfonamide apoptosis promoters |
| US7642260B2 (en) | 2003-11-13 | 2010-01-05 | Abbott Laboratories, Inc. | Apoptosis promoters |
| US7973161B2 (en) | 2003-11-13 | 2011-07-05 | Abbott Laboratories | Apoptosis promoters |
| US20060182781A1 (en) | 2004-04-30 | 2006-08-17 | Allergan, Inc. | Methods for treating ocular conditions with cyclic lipid contraining microparticles |
| GB0411166D0 (en) | 2004-05-19 | 2004-06-23 | Bionovate Ltd | Treatment for asthma and arthritis |
| MXPA06014754A (es) | 2004-06-17 | 2007-06-22 | Infinity Pharmaceuticals Inc | Compuestos y metodos para inhibir la interaccion de las proteinas bcl con los componentes de enlace. |
| US7842815B2 (en) | 2004-06-17 | 2010-11-30 | Infinity Pharmaceuticals, Inc. | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| US7893278B2 (en) | 2004-06-17 | 2011-02-22 | Hoffman-La Roche Inc. | CIS-imidazolines |
| GB0418388D0 (en) | 2004-08-18 | 2004-09-22 | Univ Newcastle | Cell therapy |
| WO2006039704A2 (en) * | 2004-09-30 | 2006-04-13 | Janssen Pharmaceutica, N.V. | Pharmaceutical composition and method for treating a joint capsule arthropathy |
| PL1888550T3 (pl) | 2005-05-12 | 2014-12-31 | Abbvie Bahamas Ltd | Promotory apoptozy |
| US8624027B2 (en) * | 2005-05-12 | 2014-01-07 | Abbvie Inc. | Combination therapy for treating cancer and diagnostic assays for use therein |
| MX2007014783A (es) | 2005-05-24 | 2008-02-19 | Abbott Lab | Activadores de apoptosis. |
| JP4870778B2 (ja) | 2005-12-01 | 2012-02-08 | エフ．ホフマン−ラ ロシュ アーゲー | 抗ガン剤として使用されるｐ５３およびｍｄｍ２タンパク質間の相互作用の阻害剤としての２，４，５−トリフェニルイミダゾリン誘導体 |
| ES2616296T3 (es) | 2005-12-02 | 2017-06-12 | (Osi) Eyetech, Inc. | Micropartículas de liberación controlada |
| KR101015073B1 (ko) | 2006-01-18 | 2011-02-16 | 에프. 호프만-라 로슈 아게 | Ｍｄｍ2 억제제로서의시스-4,5-비아릴-2-헤테로시클릭-이미다졸린 |
| WO2008014216A1 (en) * | 2006-07-28 | 2008-01-31 | St. Jude Children's Research Hospital | Method for treating ocular cancer |
| US8470785B2 (en) * | 2006-07-28 | 2013-06-25 | St. Jude Children's Research Hospital | Method for treating ocular cancer |
| WO2008017121A1 (en) | 2006-08-11 | 2008-02-14 | The Walter And Eliza Hall Institute Of Medical Research | Methods for modulating apoptosis in platelets |
| NZ575193A (en) * | 2006-08-30 | 2011-12-22 | Unversity Of Michigan | Small molecule inhibitors of MDM2 comprising a spiropyrrolidine |
| JP5277168B2 (ja) | 2006-09-05 | 2013-08-28 | アボット・ラボラトリーズ | 血小板過剰を治療するｂｃｌインヒビター |
| WO2008033747A2 (en) * | 2006-09-11 | 2008-03-20 | Curis, Inc. | Multi-functional small molecules as anti-proliferative agents |
| CN101641338A (zh) * | 2006-09-11 | 2010-02-03 | 柯瑞斯公司 | 作为抗增殖制剂的多功能小分子 |
| EP2094672B1 (en) | 2006-11-15 | 2013-05-29 | Genentech, Inc. | Arylsulfonamide compounds |
| US20100087436A1 (en) | 2006-11-16 | 2010-04-08 | Abbott Laboratories | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| US20080125487A1 (en) * | 2006-11-17 | 2008-05-29 | Tapas Das | Elongase gene and uses thereof |
| AR064010A1 (es) | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| WO2008106507A2 (en) * | 2007-02-27 | 2008-09-04 | University Of South Florida | Mdm2/mdmx inhibitor peptide |
| AU2008229648A1 (en) | 2007-03-20 | 2008-09-25 | The Walter And Eliza Hall Institute Of Medical Research | Method of screening |
| EA200901212A1 (ru) * | 2007-03-29 | 2010-04-30 | Новартис Аг | 3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеваний |
| US7625895B2 (en) | 2007-04-12 | 2009-12-01 | Hoffmann-Le Roche Inc. | Diphenyl-dihydro-imidazopyridinones |
| US20090118135A1 (en) | 2007-06-08 | 2009-05-07 | The Burnham Institute | Methods and compounds for regulating apoptosis |
| US20110028437A1 (en) | 2007-07-31 | 2011-02-03 | Limerick Biopharma, Inc. | Phosphorylated pyrone analogs and methods |
| US8283160B2 (en) | 2007-09-11 | 2012-10-09 | Frey Ii William H | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| US20100310504A1 (en) * | 2007-09-26 | 2010-12-09 | Lowe Scott W | Methods for treating fibrosis by modulating cellular senescence |
| EP2193127A4 (en) | 2007-09-27 | 2011-09-14 | Inst Medical W & E Hall | BENZOTHIAZOLE COMPOUNDS |
| EP2205088B1 (en) | 2007-10-19 | 2018-02-21 | Burnham Institute for Medical Research | Naphthalene-based inhibitors of anti-apoptotic proteins |
| WO2009085216A2 (en) | 2007-12-20 | 2009-07-09 | Squicor | Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease |
| WO2009105234A2 (en) | 2008-02-19 | 2009-08-27 | Combinatorx, Incorporated | Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein |
| US8470607B2 (en) | 2008-03-20 | 2013-06-25 | Morphotek, Inc. | Inhibition of angiogenesis |
| US20110070184A1 (en) | 2008-03-24 | 2011-03-24 | Carolus Therpeutics, Inc. | Methods and compositions for treating atherosclerosis and related condidtions |
| US7782903B2 (en) | 2008-05-14 | 2010-08-24 | Newport Media, Inc. | Hardware accelerated protocol stack |
| RU2553225C2 (ru) | 2008-05-23 | 2015-06-10 | Сива Корпорейшн | Способ облегчения регенерации |
| WO2009151069A1 (ja) * | 2008-06-12 | 2009-12-17 | 第一三共株式会社 | ４，７－ジアザスピロ［２．５］オクタン環構造を有するイミダゾチアゾール誘導体 |
| US8168784B2 (en) | 2008-06-20 | 2012-05-01 | Abbott Laboratories | Processes to make apoptosis promoters |
| AU2009271129B2 (en) | 2008-07-14 | 2013-10-10 | Otonomy, Inc. | Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| CA2740124A1 (en) | 2008-10-09 | 2010-04-15 | Waratah Pharmaceuticals Inc. | Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
| CN101507729B (zh) * | 2008-10-23 | 2010-12-22 | 昆明诺唯金参生物工程有限责任公司 | 人参皂苷Compound K在制备防治动脉粥样硬化的药物中的应用 |
| US20100160322A1 (en) | 2008-12-04 | 2010-06-24 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| US8563735B2 (en) | 2008-12-05 | 2013-10-22 | Abbvie Inc. | Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| US8586754B2 (en) | 2008-12-05 | 2013-11-19 | Abbvie Inc. | BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| EP3549951A3 (en) * | 2008-12-09 | 2019-11-20 | Dana Farber Cancer Institute, Inc. | Methods and compositions for specific modulation of mcl-1 |
| US20130302283A1 (en) * | 2012-05-14 | 2013-11-14 | Advanced Technologies And Regenerative Medicine, Llc | hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS |
| NZ593536A (en) | 2008-12-19 | 2013-07-26 | Genentech Inc | Quinoline derivatives and methods of use |
| WO2010080503A1 (en) | 2008-12-19 | 2010-07-15 | Genentech, Inc. | Heterocyclic compounds and methods of use |
| CA2747835A1 (en) | 2009-01-19 | 2010-07-22 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| AU2010234360A1 (en) * | 2009-04-09 | 2011-09-29 | Oncothyreon, Incorporated | Methods and compositions of PI-3 kinase inhibitors for treating fibrosis |
| BRPI1010655A2 (pt) | 2009-04-10 | 2019-09-03 | Qi Haiyan | novos agentes antienvelhecimento e métodos para identificá-los |
| US8362013B2 (en) * | 2009-04-30 | 2013-01-29 | Abbvie Inc. | Salt of ABT-263 and solid-state forms thereof |
| US8546399B2 (en) | 2009-05-26 | 2013-10-01 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
| WO2010148447A1 (en) | 2009-06-23 | 2010-12-29 | Centenary Institute Of Cancer Medicine And Cell Biology | A novel regulator of cellular senescence |
| BR112012006252A2 (pt) * | 2009-09-20 | 2017-05-23 | Abbott Lab | "formas cristalinas de abt-263 e solvatos para o uso no tratamento de doenças relacionadas á proteína bcl-2". |
| PE20121172A1 (es) | 2009-10-14 | 2012-09-05 | Merck Sharp & Dohme | Piperidinas sustituidas con actividad en la hdm2 |
| US20120283269A1 (en) | 2009-11-04 | 2012-11-08 | Health Research Inc. | Method and Compositions for Suppression of Aging |
| TW201127384A (en) | 2009-11-18 | 2011-08-16 | Nerviano Medical Sciences Srl | Therapeutic combination comprising a Cdc7 inhibitor and an antineoplastic agent |
| US8658170B2 (en) * | 2010-01-06 | 2014-02-25 | Joseph P. Errico | Combination therapy with MDM2 and EFGR inhibitors |
| WO2011083150A2 (en) | 2010-01-07 | 2011-07-14 | Akron Molecules Gmbh | Obesity small molecules |
| WO2011098262A2 (en) | 2010-02-09 | 2011-08-18 | Universität Bremen | P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth |
| US10159669B2 (en) | 2010-03-02 | 2018-12-25 | Ian H. Chan | Individual and combination of mdivi-1 and nutlin-3 for topical or intravitreal ophthalmic use |
| RU2015141713A (ru) | 2010-03-25 | 2018-12-28 | Эббви Инк. | Средства, индуцирующие апоптоз, для лечения рака, иммунных и аутоиммунных заболеваний |
| US8675704B2 (en) | 2010-04-29 | 2014-03-18 | Sri International | Single ridge N-P-N diode laser |
| TWI520960B (zh) | 2010-05-26 | 2016-02-11 | 艾伯維有限公司 | 用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑 |
| US20120005765A1 (en) | 2010-07-01 | 2012-01-05 | Saint Louis University | Animal model for parkinson's disease |
| US20130287763A1 (en) * | 2010-07-28 | 2013-10-31 | Merck Sharp & Dohme Corp. | Combination therapy for treating cancer comprising an igf-1r inhibitor and an akt inhibitor |
| TWI535712B (zh) | 2010-08-06 | 2016-06-01 | 阿斯特捷利康公司 | 化合物 |
| ES2705027T3 (es) | 2010-08-19 | 2019-03-21 | Buck Institute For Age Res | Métodos de tratamiento del deterioro cognitivo leve (DCL) y trastornos relacionados |
| US9102668B2 (en) | 2010-09-08 | 2015-08-11 | Glaxo Group Limited | Polymorphs and salts |
| WO2012047587A2 (en) | 2010-09-27 | 2012-04-12 | Serrata, Llc | Mdm2 inhibitors for treatment of ocular conditions |
| WO2012045018A1 (en) | 2010-09-30 | 2012-04-05 | St. Jude Children's Research Hospital | Aryl-substituted imidazoles |
| FR2966040A1 (fr) | 2010-10-19 | 2012-04-20 | Brigitte Gourlaouen | Composition amincissante et/ou de prevention des processus inflammatoires |
| CA3152557A1 (en) | 2010-10-29 | 2012-05-03 | Abbvie Inc. | Solid dispersions containing an apoptosis-inducing agent |
| UA113500C2 (xx) | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
| US8741905B2 (en) | 2010-11-05 | 2014-06-03 | The Broad Institute, Inc. | Compounds and methods for treating autoimmune diseases |
| SG190204A1 (en) * | 2010-11-11 | 2013-06-28 | Redx Pharma Ltd | Drug derivatives |
| CA2817568A1 (en) | 2010-11-12 | 2012-05-18 | The Salk Institute For Biological Studies Intellectual Property And Tech Nology Transfer | Cancer therapies and diagnostics |
| JP2014500870A (ja) | 2010-11-12 | 2014-01-16 | ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン | スピロ−オキシインドールｍｄｍ２アンタゴニスト |
| ES2603129T3 (es) | 2010-11-23 | 2017-02-23 | Abbvie Ireland Unlimited Company | Métodos de tratamiento utilizando inhibidores selectivos de Bcl-2 |
| EP2668180B1 (en) | 2011-01-25 | 2018-08-01 | The Regents of The University of Michigan | Bcl-2/bcl-xl inhibitors for use in the treatment of cancer |
| EP2667874A4 (en) | 2011-01-27 | 2014-07-30 | Univ Princeton | MTOR KINASE HEMMER AS ANTIVIRUS AGENT |
| US9737532B2 (en) * | 2011-01-31 | 2017-08-22 | Tokyo University Of Science Foundation | Method of treating ischemia/reperfusion injury |
| CN103458970A (zh) | 2011-03-07 | 2013-12-18 | 泰莱托恩基金会 | Tfeb磷酸化抑制剂及其应用 |
| KR101426689B1 (ko) * | 2011-04-19 | 2014-08-08 | 가톨릭대학교 산학협력단 | Ｎｕｔｌｉｎ３ａ 화합물을 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 |
| TWI497333B (zh) | 2011-06-14 | 2015-08-21 | Giant Mfg Co Ltd | 自行車適配產生方法、自行車適配系統與電腦程式產品 |
| WO2012177927A1 (en) | 2011-06-21 | 2012-12-27 | Mayo Foundation For Medical Education And Research | Transgenic animals capable of being induced to delete senescent cells |
| US20140328893A1 (en) | 2011-10-11 | 2014-11-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nutlin compounds for use in the treatment of pulmonary hypertension |
| US8940737B2 (en) | 2011-10-14 | 2015-01-27 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| US9140213B2 (en) * | 2011-12-06 | 2015-09-22 | United Technologies Corporation | Leaf spring damper for a turbine engine fuel delivery system |
| MX2014007093A (es) | 2011-12-13 | 2014-10-13 | Buck Inst For Res On Aging | Metodos para mejorar terapias medicas. |
| US8747112B2 (en) | 2011-12-30 | 2014-06-10 | Nobel Biocare Services Ag | Abutment position locator |
| KR20140127307A (ko) | 2012-02-06 | 2014-11-03 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 섬유성 질병을 치료하기 위한 pi3k 억제제 |
| WO2013155077A1 (en) | 2012-04-09 | 2013-10-17 | Board Of Regents,The University Of Texas System | Response markers for src inhibitor therapies |
| US20150126573A1 (en) | 2012-05-09 | 2015-05-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for prevention or treatment of chronic obstructive pulmonary disease |
| KR101725571B1 (ko) * | 2012-06-13 | 2017-04-11 | 가톨릭대학교 산학협력단 | Ｍｄｍ２ 억제제를 유효성분으로 포함하는 노화 억제용 조성물 |
| US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
| CA2879332C (en) | 2012-08-13 | 2022-08-30 | Abbvie Inc. | 1,2,3,4- tetrahydroisoquinoline-8-carboxamide compounds and their use as apoptosis-inducing agents |
| US9104666B2 (en) | 2012-09-04 | 2015-08-11 | Oracle International Corporation | Controlling access to a large number of electronic resources |
| US8895729B2 (en) | 2012-10-10 | 2014-11-25 | Genentech, Inc. | Process for making thienopyrimidine compounds |
| EP3689886A1 (en) | 2013-01-16 | 2020-08-05 | The Regents of The University of Michigan | Bcl-2/bcl-xl inhibitors and their use in the treatment of cancer |
| WO2014121211A2 (en) | 2013-02-01 | 2014-08-07 | Zoneone Pharma, Inc. | Remote loading of sparingly water-soluble drugs into liposomes |
| US10799473B2 (en) | 2013-03-04 | 2020-10-13 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Methods of inhibiting IGF-1R activation or downtream signalling thereof to reduce radiation-induced cellular senescence |
| US20140275082A1 (en) | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| US20140272947A1 (en) | 2013-03-15 | 2014-09-18 | Fox Chase Cancer Center | Methods and compositions for screening modulators of oncogene-induced senescence |
| CN110201144B (zh) * | 2013-03-15 | 2024-01-02 | 得克萨斯州大学系统董事会 | 用Nutlin-3a和肽抑制肺纤维化 |
| RU2015149680A (ru) | 2013-04-21 | 2017-05-24 | Йеда Ресеарч Энд Девелопмент Ко. Лтд. | Агенты для подавления активности и/или снижения количества bcl-xl и/или bcl-w |
| WO2014186877A1 (en) | 2013-05-24 | 2014-11-27 | Uger Marni Diane | FasR ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE |
| TW201536324A (zh) | 2013-06-19 | 2015-10-01 | Buck Inst For Res On Aging | 增加醫藥療法有效性之方法 |
| US20160022720A1 (en) | 2013-08-02 | 2016-01-28 | Children's Hospital Medical Center | Compositions and methods for treating disease states associated with activated t cells and/or b cells |
| WO2015051252A1 (en) | 2013-10-03 | 2015-04-09 | Duke University | Compositions and methods for treating cancer with jak2 activity |
| RU2016104927A (ru) | 2013-11-01 | 2017-12-06 | Эверон Байосайенсис, Инк. | Молекулярные мишени для селективного уничтожения сенесцентных клеток |
| AU2014348657A1 (en) | 2013-11-13 | 2016-05-19 | Novartis Ag | mTOR inhibitors for enhancing the immune response |
| US10328058B2 (en) | 2014-01-28 | 2019-06-25 | Mayo Foundation For Medical Education And Research | Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques |
| US20190269675A1 (en) | 2014-01-28 | 2019-09-05 | Buck Institute for Research and Aging | Treatment of parkinson's disease and other conditions caused or mediated by senescent astrocytes using small molecule senolytic agents |
| US20190000846A1 (en) | 2014-01-28 | 2019-01-03 | Mayo Foundation For Medical Education And Research | Pharmaceutical Products and Drug Combinations for Treating Atherosclerosis by Stabilizing Atherosclerotic Plaques and Promoting Plaque Regression |
| IL286427B2 (en) | 2014-01-28 | 2024-08-01 | Mayo Found Medical Education & Res | Inhibitors bcl-2 anti-apoptotic protein family members for treatment of non cancer pulmonary disease or an opthalmic disease |
| US20170216286A1 (en) | 2014-01-28 | 2017-08-03 | Mayo Foundation For Medical Education And Research | Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid |
| EP3139942B1 (en) * | 2014-05-05 | 2019-12-18 | Bioventures, Llc | COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS |
| GB201409519D0 (en) | 2014-05-29 | 2014-07-16 | Univ Leicester | Senescent cell biomarkers |
| US20180000816A1 (en) | 2015-02-06 | 2018-01-04 | Unity Biotechnology, Inc. | Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions |
| WO2016127135A1 (en) | 2015-02-06 | 2016-08-11 | Unity Biotechnology, Inc. | Compounds and uses in treatment of senescence-associated conditons |
| US10588916B2 (en) | 2017-10-31 | 2020-03-17 | Unity Biotechnology, Inc. | Technology to inhibit vascular changes that lead to vision loss in the eye |
-
2015
- 2015-01-28 IL IL286427A patent/IL286427B2/en unknown
- 2015-01-28 US US15/114,762 patent/US9993472B2/en active Active
- 2015-01-28 CN CN202010556478.8A patent/CN112274641A/zh active Pending
- 2015-01-28 SG SG10201805670QA patent/SG10201805670QA/en unknown
- 2015-01-28 EP EP15743068.7A patent/EP3099380B1/en active Active
- 2015-01-28 CA CA3100140A patent/CA3100140C/en active Active
- 2015-01-28 IL IL311537A patent/IL311537A/en unknown
- 2015-01-28 MX MX2016009753A patent/MX2016009753A/es unknown
- 2015-01-28 CA CA2939121A patent/CA2939121C/en active Active
- 2015-01-28 NZ NZ723035A patent/NZ723035A/en unknown
- 2015-01-28 CN CN201910589846.6A patent/CN110623956A/zh active Pending
- 2015-01-28 AU AU2015211021A patent/AU2015211021B2/en not_active Ceased
- 2015-01-28 WO PCT/US2015/013387 patent/WO2015116740A1/en not_active Ceased
- 2015-01-28 BR BR112016017564A patent/BR112016017564A8/pt not_active Application Discontinuation
- 2015-01-28 CN CN201580017167.1A patent/CN106163557B/zh not_active Expired - Fee Related
- 2015-01-28 JP JP2016549442A patent/JP6688224B2/ja not_active Expired - Fee Related
- 2015-01-28 EP EP19216214.7A patent/EP3669881B1/en active Active
- 2015-01-28 RU RU2016134429A patent/RU2716256C2/ru active
- 2015-01-28 KR KR1020167023680A patent/KR102496146B1/ko active Active
- 2015-01-28 SG SG11201606239UA patent/SG11201606239UA/en unknown
-
2016
- 2016-07-26 IL IL246954A patent/IL246954B/en unknown
- 2016-07-27 MX MX2021012547A patent/MX2021012547A/es unknown
-
2017
- 2017-03-10 US US15/455,684 patent/US10213426B2/en active Active
- 2017-03-10 US US15/455,630 patent/US20170196858A1/en not_active Abandoned
- 2017-03-10 US US15/455,575 patent/US9849128B2/en active Active
- 2017-03-23 US US15/467,129 patent/US9855266B2/en active Active
- 2017-04-06 US US15/481,129 patent/US10130628B2/en active Active
- 2017-07-12 US US15/647,688 patent/US9980962B2/en active Active
- 2017-11-30 US US15/827,539 patent/US10010546B2/en active Active
-
2018
- 2018-04-11 US US15/950,965 patent/US10413542B2/en active Active
- 2018-04-17 US US15/955,542 patent/US10258618B2/en not_active Expired - Fee Related
- 2018-04-18 US US15/956,613 patent/US10478432B2/en active Active
- 2018-05-16 US US15/981,696 patent/US10517866B2/en active Active
- 2018-06-13 US US16/007,880 patent/US10478433B2/en active Active
- 2018-08-03 US US16/054,667 patent/US10328073B2/en active Active
-
2019
- 2019-04-25 JP JP2019083555A patent/JP2019142933A/ja active Pending
- 2019-07-10 US US16/508,119 patent/US20190343832A1/en not_active Abandoned
- 2019-09-26 US US16/584,638 patent/US11351167B2/en active Active
-
2020
- 2020-03-06 JP JP2020038529A patent/JP2020105213A/ja not_active Withdrawn
- 2020-10-02 AU AU2020244600A patent/AU2020244600A1/en not_active Abandoned
- 2020-10-08 US US17/066,256 patent/US20210030752A1/en active Pending
- 2020-12-07 US US17/114,376 patent/US11963957B2/en active Active
- 2020-12-07 US US17/114,379 patent/US11980616B2/en active Active
-
2021
- 2021-05-13 JP JP2021081356A patent/JP2021138712A/ja active Pending
-
2022
- 2022-10-20 AU AU2022256167A patent/AU2022256167B2/en active Active
-
2023
- 2023-07-05 JP JP2023110762A patent/JP2023126918A/ja active Pending
-
2025
- 2025-02-20 AU AU2025201216A patent/AU2025201216A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017532285A5 (https=) | ||
| JP7169693B2 (ja) | 呼吸器疾患の治療 | |
| JP6099609B2 (ja) | 肺炎症を低減するためのレボフロキサシンの吸入 | |
| JP6424210B2 (ja) | プールされた免疫グロブリンｇを用いたアルツハイマー病の亜集団の治療 | |
| RU2013155903A (ru) | Композиции, способы и устройства для респираторной доставки двух или более активных средств | |
| JP2014528474A5 (https=) | ||
| JP2008297311A (ja) | 気道疾患の処置のためのプレコナリルを含む薬学的処方物 | |
| ES3029560T3 (en) | 5-amino-2,3-dihydro-1,4-phthalazinedione as glucocorticoid-sparing agent | |
| CN102573823A (zh) | 包含反式去甲舍曲林和血清素受体1a激动剂/拮抗剂的组合物及其用途 | |
| JP5362151B2 (ja) | Ｐｇｄ２拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬 | |
| KR20120022751A (ko) | 스테로이드성［３,２?ｃ］피라졸 유도체 및 제２ 제약 활성 화합물을 포함하는 제약 조성물 | |
| JP2020536048A5 (https=) | ||
| Wang et al. | N-methyl-D-aspartate receptor activation mediates lung fibroblast proliferation and differentiation in hyperoxia-induced chronic lung disease in newborn rats | |
| UA119774C2 (uk) | Комбінації формотеролу і будесоніду для лікування хронічної обструктивної хвороби легень (хохл) | |
| JP7433331B2 (ja) | 特発性肺線維症を治療するための組成物及び方法 | |
| US6262077B1 (en) | Composition and method for treating allergic diseases | |
| US20080207667A1 (en) | Use of nalbuphine and related compounds to treat symptoms of respiratory problems | |
| CN105456265B (zh) | 一种盐酸非索非那定在制备治疗精神分裂症药物中的应用 | |
| CA3095859C (en) | Bambuterol for the treatment of alzheimer's disease | |
| JP2013542262A5 (https=) | ||
| JP2024501919A5 (https=) | ||
| CN102665705A (zh) | 包含非甾体抗炎药和秋水仙碱苷衍生物的活性成分的新组合 | |
| Armstrong et al. | The role of aclidinium bromide in the treatment of chronic obstructive pulmonary disease | |
| Walker | American Thoracic Society (ATS) 2014 International Conference-San Diego, California, USA-May 16-21, 2014 | |
| HK40058742B (zh) | 呼吸性疾病的治疗 |